VIR · Company research
Vir Biotechnology, Inc. Common Stock (VIR): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 11.6 | $1,798,562,702.55 | 1519833702.55 | 22.6595744680851064 | — | — | 7.5270676326450328 | 1.8306112130569887 | 14.58759309090466689379 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.